Research Topics
Species | Stephan von HaehlingSummaryCountry: Germany Publications
| Collaborators
|
Detail Information
Publications
Inflammatory mediators in chronic heart failure: an overviewStefan D Anker
Department of Clinical Cardiology, Imperial College School of Medicine, National Heart and Lung Institute, London, UK
Heart 90:464-70. 2004
Biomarkers for chronic heart failureMitja Lainscak
Division of Applied Cachexia Research, Department of Cardiology, Campus Virchow Clinic, Charite Universitatsmedizin Berlin, Berlin, Germany
Heart Fail Monit 5:77-82. 2007..Lastly, we anticipate the potential of biomarkers in a variety of chronic diseases with similar pathophysiology...
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failureStephan von Haehling
Applied Cachexia Research, Department of Cardiology, Charite Medical School, Berlin, Germany
J Am Coll Cardiol 50:1973-80. 2007..Our aim was assess the prognostic value of midregional pro-atrial natriuretic peptide (MR-proANP) using a new immunoassay in patients with chronic heart failure (HF)...
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trialStephan von Haehling
Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Berlin, Germany
J Am Coll Cardiol 59:585-92. 2012..This study sought to assess the effects of ursodeoxycholic acid (UDCA) on endothelial function and inflammatory markers in patients with chronic heart failure (CHF)...
Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery diseaseStephan von Haehling
Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Berlin, Germany
Int J Cardiol 162:27-32. 2012..The aim is to investigate the prognostic value of copeptin with regard to mortality and morbidity in patients with symptomatic coronary artery disease (CAD)...
Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery diseaseStephan von Haehling
Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Berlin, Germany
Clin Sci (Lond) 123:601-10. 2012..0001). MR-proANP may help in the prediction of all-cause death in patients with symptomatic CAD. Further studies should verify its prognostic value and confirm the appropriate cut-off value...
Anemia in chronic heart failure: can we treat? What to treat?Stephan von Haehling
Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, 13353 Berlin, Germany
Heart Fail Rev 17:203-10. 2012..The RED-HF study will show whether use of darbepoetin alfa in anemic patients with chronic HF will reduce the combined endpoint of death for any reason or hospitalization for heart failure...
Cardiac cachexia: a systematic overviewStephan von Haehling
Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Berlin, Germany
Pharmacol Ther 121:227-52. 2009..Other drug classes of interest comprise angiotensin-converting enzyme inhibitors, beta-blockers, anabolic steroids, beta-adrenergic agonists, anti-inflammatory substances, statins, thalidomide, proteasome inhibitors, and pentoxifylline...
Leukocyte redistribution: effects of beta blockers in patients with chronic heart failureStephan von Haehling
Applied Cachexia Research, Dept of Cardiology, Charite Medical School, Campus Virchow Clinic, Berlin, Germany
PLoS ONE 4:e6411. 2009..Here we investigate whether a leukocyte redistribution occurs in CHF and whether this effect is influenced by beta-blocker therapy...
Inflammatory biomarkers in heart failure revisited: much more than innocent bystandersStephan von Haehling
Department of Cardiology, Applied Cachexia Research, Charite Medical School, Berlin, Germany
Heart Fail Clin 5:549-60. 2009..In addition to these acute phase reactants, several adhesion molecules, and lipopolysaccharide-signaling pathways are discussed...
Anemia in heart failure: an overview of current conceptsStephan von Haehling
Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Berlin, Germany
Future Cardiol 7:119-29. 2011..Finally, this article describes the potential costs incurred by treating anemic patients with heart failure...
Annual meeting of the American Heart Association. Dallas, Texas, USA, 13-16 November 2005Stephan von Haehling
Imperial College School of Medicine, Department of Clinical Cardiology, National Heart and Lung Institute, London SW3 6LY, UK
Expert Opin Investig Drugs 15:563-9. 2006
Statins for heart failure: still caught in no man's land?Stephan von Haehling
Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, D 13353 Berlin, Germany
Clin Sci (Lond) 116:37-9. 2009....
Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failureStephan von Haehling
Department of Clinical Cardiology, Imperial College School of Medicine, National Heart and Lung Institute, Dovehouse Street, London, SW3 6LY, UK
Cardiovasc Res 73:298-309. 2007..Finally, therapeutic approaches are discussed. These include dietary advice, ongoing studies, and future possibilities...
Future prospects of anticytokine therapy in chronic heart failureStephan von Haehling
Imperial College School of Medicine, Department of Clinical Cardiology, NationalHeart and Lung Institute, Dovehouse Street, London, SW3 6LY, UK
Expert Opin Investig Drugs 14:163-76. 2005....
Effect of noradrenaline and isoproterenol on lipopolysaccharide-induced tumor necrosis factor-alpha production in whole blood from patients with chronic heart failure and the role of beta-adrenergic receptorsStephan von Haehling
Department of Clinical Cardiology, National Heart and Lung Institute, Imperial College School of Medicine, London, United Kingdom
Am J Cardiol 95:885-9. 2005..This study demonstrated that noradrenaline and isoproterenol inhibit TNF-alpha production in patients with CHF in ex vivo whole blood in a dose-dependent fashion. The beta-blocker bisoprolol abolishes this effect...
Anaemia is an independent predictor of death in patients hospitalized for acute heart failureStephan von Haehling
Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany
Clin Res Cardiol 99:107-13. 2010..Acute heart failure is associated with a poor prognosis. It is important to identify patients at increased risk of adverse events. The presence of anaemia could help in this regard...
Cachexia: a therapeutic approach beyond cytokine antagonismS von Haehling
Department of Clinical Cardiology, National Heart and Lung Institute, Royal Brompton Hospital, London, UK
Int J Cardiol 85:173-83. 2002..The role of other approaches such as proteasome-inhibitors remains to be elucidated. Alternatively, interleukin-10 and other immunosuppressive cytokines may also be able to counterbalance certain features of cachexia...
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failureStephan von Haehling
Applied Cachexia Research, Department of Cardiology, Charité Medical School Campus Virchow Klinikum, 13353 Berlin, Germany
Eur J Heart Fail 12:484-91. 2010..Adrenomedullin (ADM) is a vasodilatory peptide. Its plasma levels or its precursors have not been evaluated in large populations of patients with chronic heart failure (CHF). We sought to explore mid-regional proADM (MR-proADM)...
Statins and the role of nitric oxide in chronic heart failureStephan von Haehling
Department of Clinical Cardiology, National Heart and Lung Institute, Imperial College, School of Medicine, London, UK
Heart Fail Rev 8:99-106. 2003..The doses needed to achieve the desired effects might be much lower than those needed to treat hypercholesterolemia...
The relationship between age and production of tumour necrosis factor-alpha in healthy volunteers and patients with chronic heart failureStephan von Haehling
Department of Clinical Cardiology, National Heart and Lung Institute, London SW3 6LY, UK
Int J Cardiol 90:197-204. 2003..Elevated plasma levels of tumour necrosis factor-alpha (TNF-alpha) are present in patients with advanced chronic heart failure (CHF). However, the relationship between age and the immune response in CHF is unknown...
Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS studyStephan von Haehling
Department of Cardiology, Applied Cachexia Research, Charite Medical School, Campus Virchow Klinikum, Berlin, Germany
Eur J Heart Fail 13:656-63. 2011..In addition, we sought to study the effects of nebivolol on the development of anaemia...
Tumour necrosis factor-alpha and the failing heart--pathophysiology and therapeutic implicationsStephan von Haehling
Imperial College School of Medicine, National Heart and Lung Institute, Department of Clinical Cardiology, London, UK
Basic Res Cardiol 99:18-28. 2004..Nevertheless, TNFalpha antagonism remains a major target of CHF therapy, although counterbalancing this cytokine alone may not be sufficient...
The European Society of Cardiology working group on heart failure: Heart Failure Update 2003Stephan von Haehling
Department of Clinical Cardiology, Imperial College School of Medicine, National Heart and Lung Institute, London, UK
Heart Fail Monit 4:78-9. 2003
Cardio-renal anemia syndromeStephan von Haehling
Applied Cachexia Research, Department of Cardiology, Campus Virchow Klinikum, Charite Medical School, Berlin, Germany
Contrib Nephrol 171:266-73. 2011..In such patients, a steep increase in mortality rates has been observed. This article describes the suggested classification systems of CRAS, its clinical significance, and potential therapeutic avenues...
Cellular endotoxin desensitization in patients with severe chronic heart failureRakesh Sharma
Clinical Cardiology, NHLI, Imperial College School of Medicine, London, UK
Eur J Heart Fail 7:865-8. 2005..Production of IL-1RA is not affected. This resembles a picture indicative of LPS desensitization occurring in patients with severe CHF...
Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shockJoerg C Schefold
Department of Nephrology and Intensive Care Medicine, Charite University Medicine, Campus Virchow, Berlin, Germany
Scand J Infect Dis 42:164-71. 2010..005, r = -0.28) in the overall samples group. Thus, GM-CSF therapy is associated with decreased IDO activity and reduced kynurenine pathway catabolites in sepsis. This may be due to an improved antibacterial defence...
Whole blood endotoxin responsiveness in patients with chronic heart failure: the importance of serum lipoproteinsRakesh Sharma
Clinical Cardiology, NHLI, Imperial College School of Medicine, Dovehouse Street, SW3 6LY, London, UK
Eur J Heart Fail 7:479-84. 2005..CONCLUSIONS: Serum lipoproteins may play an important role in regulating LPS bioactivity in CHF. Very low LPS activity, at levels seen in vivo in CHF, can induce significant TNF-alpha production ex vivo...
Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survivalSabine Genth-Zotz
Clinical Cardiology, National Heart and Lung Institute, Imperial College School of Medicine, London, UK
Int J Cardiol 96:397-401. 2004..We hypothesised that circulating Hsp70 levels are elevated in patients with CHF, more so in cachechtic patients, and that Hsp70 levels would relate to mortality...
The anti-CD14 antibody IC14 suppresses ex vivo endotoxin stimulated tumor necrosis factor-alpha in patients with chronic heart failureSabine Genth-Zotz
Clinical Cardiology, National Heart and Lung Institute, Imperial College School of Medicine, London, UK
Eur J Heart Fail 8:366-72. 2006..Plasma LPS activity is elevated in patients with severe chronic heart failure (CHF). An anti-CD14 antibody, IC14, blocks TNF production in healthy volunteers. It is not known whether IC14 prevents TNF production in CHF patients...
Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failureAnja Sandek
Dept of Cardiology, Charite Universitatsmedizin, Berlin, Germany
Int J Cardiol 157:80-5. 2012..Small intestinal function may be altered in decompensated chronic heart failure (CHF) and translocating LPS may contribute to systemic inflammation observed in CHF...
Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failureSabine Genth-Zotz
Clinical Cardiology, National Heart and Lung Institute, Imperial College School of Medicine, London, United Kingdom
Am J Cardiol 90:1226-30. 2002..These results suggest that elevated plasma endotoxin activity observed in patients with HF is of pathophysiologic relevance...
A novel selective extracorporeal intervention in sepsis: immunoadsorption of endotoxin, interleukin 6, and complement-activating product 5aJoerg C Schefold
Department of Nephrology and Intensive Care Medicine, University Medicine Berlin, Charite Campus Virchow Clinic, Berlin, Germany
Shock 28:418-25. 2007..This novel strategy might open a new therapeutic avenue for an interventional extracorporeal treatment of patients with sepsis...
Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failureGabor Foldes
Department of Clinical Cardiology, National Heart and Lung Institute, Imperial College School of Medicine, London, UK
Int J Cardiol 124:80-5. 2008..Innate immune activation mediated by myocardial Toll-like receptors (TLRs) is involved in cardiovascular disease. The function and role of TLRs on peripheral leukocytes in human chronic heart failure (CHF) are not known...
Usefulness of minimal modelling to assess impaired insulin sensitivity in patients with chronic heart failureTibor Szabo
Applied Cachexia Research, Department of Cardiology, Campus Virchow Klinikum, Charite University Medical School, Berlin, Germany
Int J Cardiol 147:47-51. 2011..Their value and discriminatory power in comparison to dynamic range assessment of Si by minimal modelling are not well established...
The relationship between tumor necrosis factor-α, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failureAmalia Vaz Pérez
Competence Network Heart Failure, Department of Cardiology, Campus Virchow Klinikum, Charite Universitatsmedizin Berlin, Berlin, Germany
Int J Cardiol 141:39-43. 2010..Brain natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) are thought to reflect cardiac functional and structural damage...
The emerging role of the gut in chronic heart failureAnja Sandek
Applied Cachexia Research, Department of Cardiology, Campus Virchow Klinikum, Charite, Berlin, Germany
Curr Opin Clin Nutr Metab Care 11:632-9. 2008..Circulating cytokines act as cardiosuppressors. Their plasma levels predict increased mortality in chronic heart failure...
Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failureAidan P Bolger
Clinical Cardiology, National Heart and Lung Institute, Imperial College School of Medicine, London, United Kingdom
Am J Cardiol 90:384-9. 2002..IL-10 is, therefore, a potential therapy for use in chronic HF associated with inflammatory immune activation...
Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flowWolfram Doehner
Division of Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Berlin, Germany
Eur Heart J 28:821-8. 2007....
Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic reviewWolfram Doehner
Center for Stroke Research Berlin, Charite, Berlin, Germany
Wien Klin Wochenschr 121:293-6. 2009..Retrospective and epidemiological data for their beneficial effect in chronic obstructive pulmonary disease begin to accumulate and new fields (e.g. cancer and stroke) could be pending in the future...
Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trialStefan D Anker
Applied Cachexia Research, Department of Cardiology, Charite Campus Virchow Klinikum, Berlin, Germany
Eur Heart J 30:1331-9. 2009..The prevalence, incidence, and prognostic value of anaemia in patients with an acute myocardial infarction (AMI) complicated by heart failure is unclear...
Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markersMitja Lainscak
Department of Cardiology, Division of Applied Cachexia Research, Campus Virchow Clinic, Charite Universitatsmedizin Berlin, Germany
Int J Cardiol 132:303-11. 2009..Finally, we speculate about the potential of sharing the biomarkers over a variety of chronic diseases with similar pathophysiology...
The gut and intestinal bacteria in chronic heart failureAnja Sandek
Applied Cachexia Research, Department of Cardiology, Campus Virchow Klinikum, Charite Medical School, Augustenburger Platz 1, 13353 Berlin, Germany
Curr Drug Metab 10:22-8. 2009..Therefore, the gut poses an interesting target for therapeutic interventions in patients with CHF...
Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failureWolfram Doehner
Department of Clinical Cardiology, National Heart and Lung Institute, Imperial College, London, United Kingdom
J Am Coll Cardiol 46:1019-26. 2005..The aim of this study was to determine the significance of insulin resistance as an independent risk factor for impaired prognosis in patients with chronic heart failure (CHF)...
Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)Susann Fülster
Department of Cardiology, Applied Cachexia Research, Charite Medical School, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany
Eur Heart J 34:512-9. 2013..53, p = 0.01). Conclusion Muscle wasting is a frequent co-morbidity among patients with chronic HF. Patients with muscle wasting present with reduced exercise capacity and muscle strength, and advanced disease...
Exercise capacity and body composition in living-donor renal transplant recipients over timeDirk Habedank
Department Cardiology, Applied Cachexia Research, Charite Campus Virchow Klinikum, Berlin, Germany
Nephrol Dial Transplant 24:3854-60. 2009..Renal transplantation (RTx) restitutes the function of the failing organ and induces convalescence of the entire organism. Our study investigates whether this is accompanied by improvements in cardiovascular function and structural changes...
Endothelial dysfunction of the peripheral vascular bed in the acute phase after ischemic strokeNadja Scherbakov
Center for Stroke Research Berlin, Charite Universitatsmedizin Berlin, Berlin, Germany
Cerebrovasc Dis 33:37-46. 2012..Increased levels of ADMA have been found in chronic heart failure (CHF). We hypothesized that peripheral ED in acute ischemic stroke is associated with increased ADMA levels...
Role of iron deficiency and anemia in cardio-renal syndromesPhilipp Attanasio
Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Berlin, Germany
Semin Nephrol 32:57-62. 2012..This article summarizes studies investigating the influence of iron deficiency with or without anemia in chronic kidney disease and CHF and gives an overview of preparations of intravenous iron currently available...
Altered intestinal function in patients with chronic heart failureAnja Sandek
Department of Gastroenterology, Charite, Campus Mitte, Berlin, Germany
J Am Coll Cardiol 50:1561-9. 2007..We evaluated morphology and function of the gut in patients with chronic heart failure (CHF)...
Changes in serum creatinine in the first 24 hours after cardiac arrest indicate prognosis: an observational cohort studyDietrich Hasper
Department of Nephrology and Medical Intensive Care, Charite Universitatsmedizin Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany
Crit Care 13:R168. 2009....
Nutrition in heart failure: an updateAnja Sandek
Applied Cachexia Research, Department of Cardiology, Charite Medical School, Berlin, Germany
Curr Opin Clin Nutr Metab Care 12:384-91. 2009..Chronic heart failure (CHF) is increasingly recognized as a multisystem disease with important comorbidities such as anemia, insulin resistance, autonomic dysbalance, or cardiac cachexia...
The cholesterol paradox revisited: heart failure, systemic inflammation, and beyondStephan von Haehling
Charite Medical School, Campus Virchow Klinikum, Berlin, Germany
Heart Fail Clin 4:141-51. 2008..Also discussed is the potential of statins, which might be able to exert beneficial effects in both clinical conditions, despite lowering plasma cholesterol values...
Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptomsJörg C Schefold
Department of Nephrology and Intensive Care, Charite University Medicine, Campus Virchow Clinic, Berlin, Germany
Nephrol Dial Transplant 24:1901-8. 2009..Here we investigate Trp catabolism, IDO activity and the role of inflammation in moderate to very severe CKD and haemodialysis...
Absolute and functional iron deficiency in professional athletes during training and recoverySimon Reinke
Division of Applied Cachexia Research, Department of Cardiology, Charite Universitatsmedizin Berlin, Germany
Int J Cardiol 156:186-91. 2012..We hypothesised that physical extremes result in ID in elite athletes and that the short recovery period may be insufficient to allow a lasting replenishment of iron reserves...
Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexiaJochen Springer
Department of Cardiology, Applied Cachexia Research, Charite Medical School, Berlin, Germany
Int J Cancer 131:2187-96. 2012..Food intake and spontaneous locomotor activity were higher, indicating a higher quality of life. Inhibition of XO can reduce tissue wasting and improve survival in cancer cachexia and clearly clinical studies are needed...
Risk stratification in patients with chronic heart failure based on metabolic-immunological, functional and haemodynamic parametersRalph Herrmann
Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Berlin, Germany
Int J Cardiol 156:62-8. 2012..A vast array of parameters has been proposed to predict mortality in chronic heart failure (CHF). Their applicability into clinical practice remains challenging due to economical and availability considerations...
Biomarkers for chronic heart failure : diagnostic, prognostic, and therapeutic challengesMitja Lainscak
Division of Applied Cachexia Research, Department of Cardiology, Campus Virchow Clinic, Charite Universitatsmedizin, Berlin, Germany
Herz 34:589-93. 2009..The authors review some of those biomarkers and speculate on the possible roles of combining two or more of them...
The American Heart Association's Scientific Sessions 2006. Chicago, IL, November 12-15, 2006Stephan von Haehling
Department of Clinical Cardiology, Imperial College School of Medicine, National Heart and Lung Institute, London, UK
Heart Fail Monit 5:101-3. 2007
Systemic changes of tryptophan catabolites via the indoleamine-2,3-dioxygenase pathway in primary cervical cancerChristina Fotopoulou
Department of Gynecology and Obstetrics, Charite, Virchow Campus Clinic University Hospital, Augustenburger Platz 1, 13353 Berlin, Germany
Anticancer Res 31:2629-35. 2011..Kynurenines are involved in various diseases such as renal failure, sepsis and cancer. We aimed to investigate whether systemic levels of kynurenines are induced in primary cervical cancer (PCC)...
Assessment of serum cotinine in patients with chronic heart failure: self-reported versus objective smoking behaviourNicole Ebner
Department of Cardiology, Applied Cachexia Research, Charite Medical School, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany
Clin Res Cardiol 102:95-101. 2013..The value of self-reported smoking behaviour has not been validated in patients with HF. We sought to assess serum cotinine levels, a marker of recent tobacco exposure, in a cohort of clinically stable patients with chronic HF...
Hormonal consequences and prognosis of chronic heart failurePhilipp Attanasio
Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Berlin, Germany
Curr Opin Endocrinol Diabetes Obes 18:224-30. 2011..This review aims to highlight players of the catabolic-anabolic imbalance, regulators or appetite, and other mediators that are involved in the progression of CHF to cachexia...
Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia ConferenceThomas Kung
Applied Cachexia Research, Charite Medical School, Department of Cardiology, Campus Virchow Klinikum, Augustenburger Platz 1, D 13353 Berlin, Germany
Expert Opin Investig Drugs 19:579-85. 2010..Novel therapeutic approaches shown here include melanocortin-4 receptor antagonists, myostatin inhibition, beta-blockers, IL-6 antagonism synthetic ghrelin and vitamin D...
Statins: a treatment option for chronic heart failure?Stephan von Haehling
National Heart and Lung Institute, Department of Clinical Cardiology, Imperial College School of Medicine, London, UK
Heart Fail Monit 4:90-7. 2004..It is therefore tempting to speculate that low doses of statins still confer pleiotropic effects without lowering plasma cholesterol levels...
Interleukin-6 serum level assessment using a new qualitative point-of-care test in sepsis: A comparison with ELISA measurementsJoerg C Schefold
Department of Nephrology and Intensive Care, Charite University Medicine, Campus Virchow Clinic, Berlin, Germany
Clin Biochem 41:893-8. 2008..We investigated whether IL-6 can be assessed using a new densitometric point-of-care (POC) bedside assay...
Overview of emerging pharmacotherapy in chronic heart failureTibor Szabo
Charite Medical School, Campus Virchow Klinikum, Applied Cachexia Research, Department of Cardiology, Augustenburger Platz 1, 13353 Berlin, Germany
Expert Opin Pharmacother 10:2055-74. 2009..This review will focus on recent developments and potential future candidates of pharmacological CHF therapy...
The influence of age and sex on disease development in a novel animal model of cardiac cachexiaSandra Palus
Center for Cardiovascular Research, Charite, Campus Mitte, Berlin, Germany
Int J Cardiol 133:388-93. 2009..These models define cachexia only as a reduction in weight gain rather than weight loss. In this pilot study, we aimed to establish a model of genuine weight loss following chronic heart failure...
The European Society of Cardiology (ESC) Annual Meeting 2005Stephan von Haehling
Imperial College School of Medicine, National Heart and Lung Institute, London, UK
Heart Fail Monit 4:150-2. 2005
The need for a standardized definition for cachexia in chronic illnessJochen Springer
Animal Research Unit, Division of Applied Cachexia Research, Charit, Campus Virchow-Klinikum, Berlin, Germany
Nat Clin Pract Endocrinol Metab 2:416-7. 2006
beta-blockers in heart failure--much more than heart rate reductionStephan von Haehling
J Card Fail 8:379-80. 2002
The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failureKlaus K A Witte
Department of Academic Cardiology, Castle Hill Hospital, Castle Road, Cottingham, Hull HU16 5JQ, UK
Eur Heart J 26:2238-44. 2005..Therefore, we examined the influence of long-term multiple micronutrient supplementation on left ventricular (LV) function, levels of pro-inflammatory cytokines, and quality-of-life (QoL) in elderly patients with CHF...
Activation of the NF-kappaB system in peripheral blood leukocytes from patients with chronic heart failureEwa A Jankowska
Cardiology Department, Military Hospital, ul Weigla 5, 50 981 Wroclaw, Poland
Eur J Heart Fail 7:984-90. 2005..In vitro experiments were used to elucidate the role of lipopolysaccharide (LPS) as a stimulus for the NF-kappaB system in PBL...
Pleiotropic effects of angiotensin-converting enzyme inhibitors and the future of cachexia therapyStephan von Haehling
J Am Geriatr Soc 53:2030-1. 2005
Toll-like receptor modulation in cardiovascular disease: a target for intervention?Gabor Foldes
Semmelweis University, 1st Department of Medicine, Budapest, Hungary
Expert Opin Investig Drugs 15:857-71. 2006..Their role as potential targets for therapeutic intervention is just beginning to be appreciated and this article reviews the current status of these treatment strategies for cardiovascular disease...
Prognostic utility of growth differentiation factor-15 in patients with chronic heart failureTibor Kempf
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
J Am Coll Cardiol 50:1054-60. 2007..We explored the prognostic utility of growth differentiation factor (GDF)-15 in patients with chronic heart failure (CHF)...
Uric acid in CHF: marker or player in a metabolic disease?Wolfram Doehner
Int J Cardiol 115:156-8. 2007
Weight change with beta-blocker use: a side effect put into perspectiveTibor Szabo
Am J Med 121:e15; author reply e17. 2008
Impact of levosimendan treatment on chronic heart failureStephan von Haehling
Am J Cardiol 94:1105. 2004
Sibutramine in cardiovascular disease: is SCOUT the new STORM on the horizon?Stephan von Haehling
Eur Heart J 28:2830-1. 2007
Insulin resistance in chronic heart failureWolfram Doehner
J Am Coll Cardiol 52:239; author reply 239-40. 2008
Impact of body mass index on in-hospital outcomes following percutaneous coronary interventionGerhard-Paul Diller
Am J Cardiol 94:1478-9; author reply 1479. 2004
Uric acid as a prognostic marker in acute heart failure--new expectations from an old moleculeWolfram Doehner
Eur J Heart Fail 9:437-9. 2007
